<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gajduskova P</submitter><funding>NCI NIH HHS</funding><pagination>R120</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2394771</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Amplifications, regions of focal high-level copy number change, lead to overexpression of oncogenes or drug resistance genes in tumors. Their presence is often associated with poor prognosis; however, the use of amplification as a mechanism for overexpression of a particular gene in tumors varies. To investigate the influence of genome position on propensity to amplify, we integrated a mutant form of the gene encoding dihydrofolate reductase into different positions in the human genome, challenged cells with methotrexate and then studied the genomic alterations arising in drug resistant cells.&lt;h4>Results&lt;/h4>We observed site-specific differences in methotrexate sensitivity, amplicon organization and amplification frequency. One site was uniquely associated with a signifi</pubmed_abstract><journal>Genome biology</journal><pubmed_title>Genome position and gene amplification.</pubmed_title><pmcid>PMC2394771</pmcid><funding_grant_id>R33 CA094407</funding_grant_id><funding_grant_id>CA90421</funding_grant_id><funding_grant_id>CA94407</funding_grant_id><funding_grant_id>R01 CA090421</funding_grant_id><pubmed_authors>Tokuyasu T</pubmed_authors><pubmed_authors>Gajduskova P</pubmed_authors><pubmed_authors>Kwek S</pubmed_authors><pubmed_authors>Roydasgupta R</pubmed_authors><pubmed_authors>Pinkel D</pubmed_authors><pubmed_authors>Fridlyand J</pubmed_authors><pubmed_authors>Snijders AM</pubmed_authors><pubmed_authors>Albertson DG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genome position and gene amplification.</name><description>&lt;h4>Background&lt;/h4>Amplifications, regions of focal high-level copy number change, lead to overexpression of oncogenes or drug resistance genes in tumors. Their presence is often associated with poor prognosis; however, the use of amplification as a mechanism for overexpression of a particular gene in tumors varies. To investigate the influence of genome position on propensity to amplify, we integrated a mutant form of the gene encoding dihydrofolate reductase into different positions in the human genome, challenged cells with methotrexate and then studied the genomic alterations arising in drug resistant cells.&lt;h4>Results&lt;/h4>We observed site-specific differences in methotrexate sensitivity, amplicon organization and amplification frequency. One site was uniquely associated with a signifi</description><dates><release>2007-01-01T00:00:00Z</release><publication>2007</publication><modification>2026-04-30T14:57:44.364Z</modification><creation>2026-04-07T16:04:47.253Z</creation></dates><accession>S-EPMC2394771</accession><cross_references><pubmed>17584934</pubmed><doi>10.1186/gb-2007-8-6-r120</doi></cross_references></HashMap>